Biotricity (NASDAQ:BTCY) Stock Price Up 26.2% – Still a Buy?

Biotricity, Inc. (NASDAQ:BTCY) shares traded up 26.2% on Friday . The stock traded as high as $0.40 and last traded at $0.39. 48,209 shares traded hands during trading, a decline of 20% from the average session volume of 60,134 shares. The stock had previously closed at $0.31.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “neutral” rating on shares of Biotricity in a research note on Monday, November 18th.

Biotricity Trading Up 26.2 %

The stock has a 50 day simple moving average of $0.32 and a 200-day simple moving average of $0.41. The firm has a market cap of $9.47 million, a PE ratio of -0.28 and a beta of 1.08.

Institutional Trading of Biotricity

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC bought a new position in Biotricity, Inc. (NASDAQ:BTCY) during the second quarter, according to its most recent 13F filing with the SEC. The fund bought 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned about 0.45% of Biotricity as of its most recent SEC filing. Institutional investors and hedge funds own 3.89% of the company’s stock.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.